Applied Finance Capital Management LLC Cuts Stake in HCA Healthcare, Inc. $HCA

Applied Finance Capital Management LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,988 shares of the company’s stock after selling 60 shares during the quarter. Applied Finance Capital Management LLC’s holdings in HCA Healthcare were worth $1,528,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. GAMMA Investing LLC boosted its position in shares of HCA Healthcare by 17.6% during the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after purchasing an additional 737 shares in the last quarter. Sowell Financial Services LLC purchased a new position in shares of HCA Healthcare in the 1st quarter valued at about $999,000. Essex Savings Bank grew its position in HCA Healthcare by 8.1% during the first quarter. Essex Savings Bank now owns 855 shares of the company’s stock worth $295,000 after buying an additional 64 shares during the period. Finally, State of Alaska Department of Revenue lifted its position in shares of HCA Healthcare by 0.8% during the 1st quarter. State of Alaska Department of Revenue now owns 20,955 shares of the company’s stock valued at $7,241,000 after acquiring an additional 160 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $444.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 7th. Bank of America increased their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research note on Wednesday, September 10th. The Goldman Sachs Group began coverage on shares of HCA Healthcare in a report on Tuesday. They issued a “buy” rating and a $470.00 price target on the stock. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Finally, JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $431.07.

HCA Healthcare Trading Down 0.2%

HCA Healthcare stock opened at $419.53 on Friday. The stock has a fifty day moving average price of $409.17 and a 200 day moving average price of $377.66. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $439.01. The firm has a market capitalization of $98.17 billion, a P/E ratio of 17.63, a PEG ratio of 1.33 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the firm posted $5.50 EPS. The company’s revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.